摘要
目的:了解β受体阻断药应用状况及变化趋势,为临床合理用药提供科学依据。方法:对武汉亚洲心脏病医院2003-2004年应用β受体阻断药的数据资料进行统计分析。结果:β受体阻断药的用药金额和用药频度逐年增加。结论:我院β受体阻断药用药合理,第二代β受体阻断药美托洛尔、阿替洛尔仍占主导地位。
Objective:To investigate the status and tendency of β-receptor antagonists usage, and offer scientific basis for reasonable usage of the drugs ib clinic treatment. Methods:The data of β-receptor antagonists usage in Wuhan Asia Heart Hospital during 2003 to 2004 were collected and analyzed. Results:The expense and frequency of β-receptor antagonists usage increase year by year. Conclusion :The usage of β-receptor antagonists is reasonable in our hospital. The second generation of β-receptor antagonists, such as metoprolol and atenolol, are donlinant in clinic use.
出处
《药学实践杂志》
CAS
2005年第5期282-284,共3页
Journal of Pharmaceutical Practice
关键词
Β受体阻断剂
DDD
用药频度
β-receptor antagonists DDD,usage frequency of drugs